JPS61271992A - Production of optically active diol - Google Patents
Production of optically active diolInfo
- Publication number
- JPS61271992A JPS61271992A JP11315985A JP11315985A JPS61271992A JP S61271992 A JPS61271992 A JP S61271992A JP 11315985 A JP11315985 A JP 11315985A JP 11315985 A JP11315985 A JP 11315985A JP S61271992 A JPS61271992 A JP S61271992A
- Authority
- JP
- Japan
- Prior art keywords
- diol
- stirred
- room temperature
- optically active
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は光学活性(+13,2R) −1−アリールプ
ロパン−1,2−ジオールの製造方法に関し、更に詳し
くは丈ツカロミセス属ニALt (JI3.2R)−1
−アリールプロパン−1,2−ジオール生成能を有する
菌をベンズアルデヒドあるいは置換ベンズアルデヒドと
糖を含有する水中で培餐後、該培養物から(+、S、2
R) −1−アリールプロパン−1,2−ジオールを採
取する一般式
(式中Xはバラ位、メタ位もしくはオルト位に結合した
置換基でO−クロロ、0−フルオロ。Detailed Description of the Invention (Industrial Application Field) The present invention relates to a method for producing optically active (+13,2R) -1-arylpropane-1,2-diol, and more specifically, to a method for producing an optically active (+13,2R) -1-arylpropane-1,2-diol, and more specifically, to .2R)-1
- After culturing bacteria capable of producing arylpropane-1,2-diol in water containing benzaldehyde or substituted benzaldehyde and sugar,
R) General formula for collecting -1-arylpropane-1,2-diol (in the formula, X is a substituent bonded to the rose position, meta position, or ortho position, and is O-chloro or O-fluoro.
0−メチル、m−フルオロ、p−ニトロs p−クロ
ロ、p−フルオロ、p−メチル、p−メトキン等である
)で表わされるジオールの製造方法である。This is a method for producing diols represented by 0-methyl, m-fluoro, p-nitros, p-chloro, p-fluoro, p-methyl, p-methquin, etc.
本発明で得られるジオールは光学活性タタノサミン、リ
ストサミンの様な医薬品の原料や〔例えばJourna
l of Organi c C!hami 5try
、第48巻、第909頁(1983年)〕、エフェドリ
ンの様な生理活性化合物の原料(Journal of
AmericanC!bemical 5ociet
y、第79巻、第197頁、第201頁(1957年)
〕となシ得る有用な化合物である。The diol obtained in the present invention is a raw material for pharmaceuticals such as optically active tatanosamine and ristosamine [for example, Journa
l of Organi c C! hami 5try
, Vol. 48, p. 909 (1983)], raw materials for bioactive compounds such as ephedrine (Journal of
AmericanC! chemical 5ociet
y, Vol. 79, pp. 197, 201 (1957)
] It is a useful compound that can be obtained.
(従来の技術)
従来、ジオールを製造する方法としては大別して有機化
学的方法と酸素や微生物を用いる生化学的方法が知られ
ている。有機化学的方法では、一般的にはオレフィンに
過酸を用いてエポキシドとした後に開環する方法や、過
マンガン酸カリウムによシ酸化する方法等が知られてい
る。(Prior Art) Conventionally, methods for producing diols are broadly classified into organic chemical methods and biochemical methods using oxygen and microorganisms. Generally known organic chemical methods include a method in which an olefin is converted into an epoxide using a peracid and then ring-opened, and a method in which the olefin is oxidized with potassium permanganate.
(発明が解決しようとする問題点)
しかしこれらの方法は酸化剤が爆発性を有して危険であ
り、また光学活性体を製造することが困崩であるという
欠点を有する。微生物や散票を用いる生化学的方法とし
てはサツカロミセス・セレヴインアエ(8acchar
omyce6 Cereviciae)の1株を開いて
ベンズアルデヒドから(1)を製造する方法が知られて
いる。(Chemistry andIndustry
、第983頁(1977年)〕。しかしこの方法を用い
ると(1)におけるXが水素及びp−メトキシの化合物
はジオールを生成するが% p−位にクロル基あるいは
ニトロ基の様に電子吸引性の基が総合している場合には
ジオールの生成が不可能であると考えられていた。(Problems to be Solved by the Invention) However, these methods have drawbacks in that the oxidizing agent is explosive and dangerous, and it is difficult to produce optically active substances. As a biochemical method using microorganisms and dust particles, Saccharomyces cereviinae (8acchar
A method is known for producing (1) from benzaldehyde by opening a strain of P. omyce6 Cereviciae. (Chemistry and Industry
, p. 983 (1977)]. However, if this method is used, a compound in which X in (1) is hydrogen and p-methoxy will produce a diol, but if an electron-withdrawing group such as a chloro group or a nitro group is combined at the p-position, It was thought that it was impossible to produce diols.
(問題を解決する丸めの手M!、)
本発明者等は電子吸引性の置換基を有するベンズアルデ
ヒドからもジオールを製造できる菌株を検索した結果、
糖類の存在下ブツカロミセス属に鵬する菌株を使用し、
1!子供与性、あるいは吸引性のベンズアルデヒドまた
は置換基を有する種々のベンズアルデヒドからジオール
を収率良く製造できることを見い出し本発明を完成した
ものである。なお1本発明による操作は従来法に比し極
めて簡便でかつ反応条件の設定が容易であシ、収率良く
ジオールLl)を得ることができるという優れた特徴を
廟する。(The rounded hand M that solves the problem!) The present inventors searched for a strain that can produce diol from benzaldehyde that has an electron-withdrawing substituent, and found that
In the presence of sugars, using a bacterial strain that belongs to the Buttucharomyces genus,
1! The present invention was completed by discovering that diols can be produced in good yield from benzaldehydes that are child-donating or absorbing, or from various benzaldehydes having substituents. Note that the operation according to the present invention is extremely simple and easy to set reaction conditions as compared to conventional methods, and has excellent features in that diol Ll) can be obtained in good yield.
本発明において用いられる置換ベンズアルデヒドとは
一般式(II)
(式中、XはO−クロロ、0−フルオロ、 o −メチ
ル、m−フルオロ、p−ニトロ% p クロロ、p−フ
ルオロ、p−メチル、p−メトキシ等である。)であら
れせられる化合物であシ、具体的には、0−クロロベン
ズアルデヒド、〇−フルオロベンズアルデヒド、0−メ
チルベンズアルデヒド、m−フルオロベンズアルデヒド
、p−クロロベンズアルデヒド、p−フルオロベンズア
ルデヒド、p−ニトロベンズアルデヒド。The substituted benzaldehyde used in the present invention has the general formula (II) (wherein, X is O-chloro, 0-fluoro, o-methyl, m-fluoro, p-nitro% p-chloro, p-fluoro, p-methyl , p-methoxy, etc.), specifically, 0-chlorobenzaldehyde, 0-fluorobenzaldehyde, 0-methylbenzaldehyde, m-fluorobenzaldehyde, p-chlorobenzaldehyde, p- Fluorobenzaldehyde, p-nitrobenzaldehyde.
p−メチルベンズアルデヒド、p−メトキシベンズアル
デヒド等の置換ベンズアルデヒドが例示されるが、これ
らに限定されるものではなく。Examples include substituted benzaldehydes such as p-methylbenzaldehyde and p-methoxybenzaldehyde, but are not limited thereto.
を圧熱置換のベンズアルデヒドも使用できる。Benzaldehyde substituted with pressure heat can also be used.
本発明に用いられる菌はブッカロミセス属に属する菌で
あシ1代表的なものとしてはサツカロミセス・セレヴイ
シアエ(Saccharamyces Cerevis
iae)IFO0205,サツカロミセスφセレクイシ
アエy。The bacteria used in the present invention belong to the genus Bucharomyces.1 A typical example is Saccharomyces Cerevisiae.
iae) IFO0205, Satucharomyces φ serequisiae y.
0233あるいはオリエンタルドライイースト(オリエ
ンタル酵母)、スーパーカメリヤ(日清製粉)など市販
されているパン酵母を挙げることができる。Commercially available baker's yeast such as 0233, Oriental Dry Yeast (Oriental Yeast), and Super Camellia (Nissin Seifun) can be used.
反応はこれら酵母画体と水およびグルコース、ショ糖等
の糖類の混合物を20〜40℃の温度で撹拌し1発酵が
始まった時に基質であるベンズアルデヒドあるいは置換
ベンズアルデヒドをそのtま、あるいはエタノール溶液
として加え、数時間から3日間撹拌することによシ行な
われる。The reaction is carried out by stirring a mixture of these yeast extracts, water, and sugars such as glucose and sucrose at a temperature of 20 to 40°C. 1. When fermentation begins, the substrate benzaldehyde or substituted benzaldehyde is added to the mixture or as an ethanol solution. This is done by adding and stirring for several hours to three days.
また、反応液中に基質1tに対して0.3〜1.2tの
アセトアルデヒドを加えると、ベンジルアルコールへの
還元を防止することができ収率が向上する。培地のpH
は5〜10が適しているが。Further, when 0.3 to 1.2 t of acetaldehyde is added to the reaction solution per 1 t of substrate, reduction to benzyl alcohol can be prevented and the yield can be improved. pH of medium
A score of 5 to 10 is appropriate.
7〜9が更に好適である。基質の使用濃度は特に制限さ
れないが一般には0.1〜5%程度が好ましい。培養液
中からのジオールの単離は遠心分離あるいは吸引濾別等
で菌体を除いたのち。7 to 9 are more preferred. The concentration of the substrate to be used is not particularly limited, but is generally preferably about 0.1 to 5%. Diols are isolated from the culture solution after removing bacterial cells by centrifugation or suction filtration.
あるいは菌体を除くことなく培養液を例えば。Alternatively, for example, use the culture solution without removing the bacterial cells.
酢酸エチル、ンエチルエーテル等の有機溶媒で抽出しシ
リカゲル、アルミナ等を充填剤とし九カラムクロマトグ
ラフィー、あるいはシリカゲル、アルミナ等を吸着剤と
した遠心クロマトグラフイー、蒸留、再結晶など通常の
精製方法を用いて精製する。Extraction with an organic solvent such as ethyl acetate or ethyl ether, followed by nine-column chromatography using silica gel, alumina, etc. as a packing material, centrifugal chromatography using silica gel, alumina, etc. as an adsorbent, distillation, recrystallization, or other conventional purification methods. Purify using.
以下、実施例によって本発明を更に詳細に説明するが、
本発明はこれらに限られるものではない。Hereinafter, the present invention will be explained in more detail with reference to Examples.
The present invention is not limited to these.
実施例1
pH9のりン駿塩緩衝液50m、乾燥酵母(オリエンタ
ルトライイースト) 12.5F、 グルコース10
ft−5001Llのナスフラスコに秤シ取シ、室温
で10分間撹拌した。これにベンズアルデヒド6101
IP(5,75mmol )のエタノール溶液(1s+
l)及びアセトアルデヒド480 q(11mmol
)を加えてそのまt室温でマグミキサーを用いて撹拌し
九。Example 1 Phosphorus salt buffer 50m pH 9, dry yeast (Oriental Tri Yeast) 12.5F, glucose 10
The mixture was weighed into a ft-5001 L eggplant flask and stirred at room temperature for 10 minutes. In this, benzaldehyde 6101
IP (5.75 mmol) in ethanol solution (1s+
l) and acetaldehyde 480 q (11 mmol
) and stir using a mug mixer at room temperature.
1時間後更に乾燥酵母(オリエンタルドライイースト)
6.3 tとグルコース52を加えて更に室温で3.
5時間撹拌した。ついで、セライト35tを入れたビー
カーに反応液を注ぎ、I&引瀘別した後100mgの酢
酸エチルで3回抽出した。有機層は合せて無水硫酸ナト
リウムで乾燥し、減圧下で溶媒を留去し死後、シリカゲ
ルのカラムクロマトグラフィー(溶離剤:ヘキサンー酢
酸エチル=4 : r )で(IR,2B) −1−フ
ェニルプロパン−1,2−ジオールの光学活性体を油状
物として385岬を得た。その収率は44%であった。After 1 hour, add dry yeast (Oriental dry yeast)
6.3 t and glucose 52 were added and further heated at room temperature for 3.
Stirred for 5 hours. Then, the reaction solution was poured into a beaker containing 35 tons of Celite, filtered and filtered, and extracted three times with 100 mg of ethyl acetate. The organic layers were combined and dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. After death, silica gel column chromatography (eluent: hexane-ethyl acetate = 4:r) was performed to extract (IR, 2B)-1-phenylpropane. 385 Misaki was obtained by using an optically active form of -1,2-diol as an oil. The yield was 44%.
赤外吸収(Neat ) air’
5400、3080.2900.1650.1500.
1450゜+380.1200. +130.1080
.1040. 990゜核磁気共鳴吸収(cc14)
δppm = 1.07(d、 3H)2 、77 (
broad a、2H)4、 Oo (axquart
I H)4.63(d、IH)
7、16〜7.5(m、5H)
質量分析スペクトル(m/z、 rel 1ntens
ity)+35(99)、 108(100)、 79
(88)、 45(16)、 27(り比旋光度
〔α)D−38,9° (C!=2.05. C!HO
1,)実施例2
乾燥酵母12.5 f、グルコースIO?、水道水50
dをナスフラスコに秤シ取り、室温で10分間撹拌した
。これにp−クロロベンズアルデヒド0.605 f
(3,24mmol)のエタノール溶液1dを加え、そ
のまtg温で1時間撹拌した。ここで乾燥酵母6.5t
とグルコース5fを加え、更に3.5時間室温で撹拌し
た。ついで、セライト35tを入れたビーカーに反応液
を注ぎ、以下実施例1と同様にして酢酸エチルで抽出、
無水硫酸ナトリウムで乾燥し、溶媒を留去した後、シリ
カゲルカラムクロマトグラフィー(溶離剤:へ ′キサ
ンー酢酸エチル=4:I)で(IR,28) −1−(
p−クロロフェニル)−グロバンー1.2−ジオールの
光学活性体を油状物として0.220 f得た。その収
率は27Xであった。Infrared absorption (Neat) air' 5400, 3080.2900.1650.1500.
1450°+380.1200. +130.1080
.. 1040. 990° nuclear magnetic resonance absorption (cc14) δppm = 1.07 (d, 3H)2, 77 (
broad a, 2H) 4, Oo (axquart
IH) 4.63 (d, IH) 7, 16-7.5 (m, 5H) Mass spectrometry spectrum (m/z, rel 1ntens
ity)+35(99), 108(100), 79
(88), 45 (16), 27 (specific optical rotation [α) D-38,9° (C!=2.05. C!HO
1,) Example 2 Dry yeast 12.5 f, glucose IO? , tap water 50
d was weighed into an eggplant flask and stirred at room temperature for 10 minutes. Add 0.605 f of p-chlorobenzaldehyde to this.
(3.24 mmol) of ethanol solution was added thereto, and the mixture was stirred at tg temperature for 1 hour. Here, 6.5 tons of dry yeast
and glucose 5f were added, and the mixture was further stirred at room temperature for 3.5 hours. Next, the reaction solution was poured into a beaker containing 35 tons of Celite, and extracted with ethyl acetate in the same manner as in Example 1.
After drying over anhydrous sodium sulfate and distilling off the solvent, (IR, 28) -1-(
0.220 f of an optically active form of p-chlorophenyl)-globan-1,2-diol was obtained as an oil. The yield was 27X.
赤外線吸収(Neat) an”’
3400、3000.2950.1910.1720.
1600゜1500、 +410.1200. 930
. 850. 800゜740、 720
核磁気共鳴吸収(cc14)
δppm = 0.95(d、3H)
3、15(broad 8.2H)
3.85(d X quart、 IH)4.59((
1,In)
7.08〜7.43(m、 4H)
質量分析スペクトル(+!!/2. rel 1nte
nsity)186(2)、 169(2)、 1
41(100)、 +07(1)。Infrared absorption (Neat) an'' 3400, 3000.2950.1910.1720.
1600°1500, +410.1200. 930
.. 850. 800°740, 720 Nuclear magnetic resonance absorption (cc14) δppm = 0.95 (d, 3H) 3, 15 (broad 8.2H) 3.85 (d X quart, IH) 4.59 ((
1, In) 7.08-7.43 (m, 4H) Mass spectrometry spectrum (+!!/2. rel 1nte
nsity) 186(2), 169(2), 1
41 (100), +07 (1).
77(40)、 45(9)、 28(17)比旋光
度
〔α〕もj −37,6° (C!=2.00.
cHcl、)匣施例3
乾燥酵母+2,5 f、グル:ff −ス10p、水道
水50dをナスフラスコに秤シ取シ、室温で10分間撹
拌した。これに0−クロロベンズアルデヒド0.607
? (4,32mmol)のエタノール溶液1dを加
え、そのまま室温で1時間撹拌した。ここで乾燥酵母6
.32とクルコース5fを加え、更に3.5時間室温で
撹拌した。ついで、セライト3うtを入れたビーカーに
反応液を注ぎ、以下実施例1と同様にして酢酸エチルで
抽出、無水硫酸ナトリウムで乾燥し、溶媒を留去した後
、シリカゲルカラムクロマトグラフィー(溶離剤:ヘキ
サンー酢酸エチル=4:+)で(IFI、2B) −1
−(0−クロロフェニル)−プロパン−1,2−ジオー
ルの光学活性体を油状物として0.256 F得た。そ
の収率は52九であった。77(40), 45(9), 28(17) The specific optical rotation [α] is also j −37,6° (C!=2.00.
cHcl, ) Box Example 3 Dry yeast + 2.5 f, Glue: ff -su 10 p, and tap water 50 d were weighed into an eggplant flask and stirred at room temperature for 10 minutes. To this, 0-chlorobenzaldehyde 0.607
? (4.32 mmol) of ethanol solution was added thereto, and the mixture was stirred at room temperature for 1 hour. Here dry yeast 6
.. 32 and Cucrose 5f were added, and the mixture was further stirred at room temperature for 3.5 hours. Next, the reaction solution was poured into a beaker containing 3 tons of Celite, extracted with ethyl acetate in the same manner as in Example 1, dried over anhydrous sodium sulfate, distilled off the solvent, and subjected to silica gel column chromatography (eluent :hexane-ethyl acetate = 4:+) (IFI, 2B) -1
An optically active form of -(0-chlorophenyl)-propane-1,2-diol was obtained as an oil with a weight of 0.256 F. The yield was 529.
赤外吸収(Neat) cIn4
3400、3000.2950. +710.1600
.1570゜3440、1200. 930. 850
. 760. 710核磁気共鳴吸収(ccx、)
δppm = 0.90(d、3H)
3.70(broad S、2H)
4.16((I X quart、 IH)5.13(
a、11)
7.01〜7.0(m、3H)
7.43〜7.75 (m、IH)
質量分析スペクトル(ル’z rel 1ntensi
ty)186(1)、 169(2)、 152(2
)、 141(59)、 105(44ニア7(10
0)、 45(47)、 29(22)、 14(60
)比旋光度
(α)”、; −31,8° (C!=1.390H
CIg)実施例4
乾燥酵母+2.5f、グルコース102、水道水50d
をナスフラスコに秤シ取)、室温で10分間撹拌シた。Infrared absorption (Neat) cIn4 3400, 3000.2950. +710.1600
.. 1570°3440, 1200. 930. 850
.. 760. 710 Nuclear magnetic resonance absorption (ccx,) δppm = 0.90 (d, 3H) 3.70 (broad S, 2H) 4.16 ((I X quart, IH) 5.13 (
a, 11) 7.01-7.0 (m, 3H) 7.43-7.75 (m, IH) Mass spectrometry spectrum (le'z rel 1ntensi
ty) 186(1), 169(2), 152(2
), 141 (59), 105 (44 near 7 (10
0), 45 (47), 29 (22), 14 (60
) Specific optical rotation (α)''; -31,8° (C!=1.390H
CIg) Example 4 Dry yeast +2.5f, glucose 102, tap water 50d
(weighed into an eggplant flask) and stirred at room temperature for 10 minutes.
これにp−フルオロベンズアルデヒド0.6049 (
4,87mmol)のエタノール溶液1dを加え、その
まま室温で1時間撹拌した。ここで乾燥酵母6.3vと
グルコース5fを加え、史に5.5時間室温で撹拌した
。ついで、セライト35?を入れたビーカーに反応液を
注ぎ、以下実施例1と同様にして酢酸エチルで抽出、無
水硫酸ナトリウムで乾燥し、溶媒を留去した後、シリカ
ゲルカラムクロマトグラフィー(溶離剤:ヘキサンー酢
酸エサル=4:1)で(IR,2B) −1−(p−フ
ルオロフェニル)−プロパン−1,2−ジオールの光学
活性体を油状物として0.214を得た。その収率は2
6%であった。To this, 0.6049 p-fluorobenzaldehyde (
4.87 mmol) of ethanol solution (1 d) was added thereto, and the mixture was stirred as it was at room temperature for 1 hour. Here, 6.3v of dry yeast and 5f of glucose were added, and the mixture was stirred at room temperature for 5.5 hours. Next, Celite 35? The reaction solution was poured into a beaker containing 100% chloride, extracted with ethyl acetate in the same manner as in Example 1, dried over anhydrous sodium sulfate, the solvent was distilled off, and then subjected to silica gel column chromatography (eluent: hexane-ethyl acetate = 4 :1) to obtain 0.214 as an optically active form of (IR, 2B) -1-(p-fluorophenyl)-propane-1,2-diol as an oil. The yield is 2
It was 6%.
:。:.
赤外線吸収(Neat) arr’
3400.3000,2900.+900.1700.
1605゜1510、 +450. 1220. 9
30. 850. 820゜核磁気共鳴吸収(ccl、
)
δppm = 0.90(d、 3H)5 、80 (
dXquart 、 IH)4.23(broad S
、2H)
今、53(d、IH)
6.73〜7.50(m、4H)
質量分析スペクトル(n1/z rel 1ntens
ity)170(υ、9)、 +53(14)、
+25(100)。Infrared absorption (Neat) arr' 3400.3000,2900. +900.1700.
1605°1510, +450. 1220. 9
30. 850. 820° nuclear magnetic resonance absorption (ccl,
) δppm = 0.90 (d, 3H)5, 80 (
dXquart, IH) 4.23 (broad S
, 2H) Now, 53 (d, IH) 6.73-7.50 (m, 4H) Mass spectrometry spectrum (n1/z rel 1ntens
ity) 170 (υ, 9), +53 (14),
+25 (100).
97(51)、 77(15)、 45(+3)、 2
8(22)比旋光度
(a)”a’ −ss、9°(a = 2.Of c
aclg)実施例5
乾燥酵母12.5r、グルコース!Of、水道水501
IJt−ナスフラスコに秤シ取り、室温で10分間撹拌
した。これにm−フルオロベンズアルデヒド0.605
9 (4,88mmol)のエタノール溶液1mを加え
、そのまま室温で1時間撹拌した。ここで乾燥酵母6.
32とグルコース52を加え、更に3.5時間室温で撹
拌した。ついで、セライト35tを入れたビーカーに反
応液を注ぎ、以下冥施例暑と同様にして酢酸エチルで抽
出、無水硫酸ナトリウムで乾燥し、溶媒を留去した後、
シリカゲルカラムクロマトグラフィー(溶離剤:ヘキサ
ンー酢酸エチル=+:1)で(IR,2B) −l−m
−フルオロフェニル−プロパン−12−ジオールの光学
活性体を油状物として0.263 r得た。その収率は
31%であった。97 (51), 77 (15), 45 (+3), 2
8 (22) Specific optical rotation (a)"a' -ss, 9° (a = 2.Of c
aclg) Example 5 Dry yeast 12.5r, glucose! Of, tap water 501
The mixture was weighed in an IJt-Eggplant flask and stirred at room temperature for 10 minutes. To this, m-fluorobenzaldehyde 0.605
9 (4.88 mmol) in ethanol was added thereto, and the mixture was stirred at room temperature for 1 hour. Here dry yeast 6.
32 and glucose 52 were added, and the mixture was further stirred at room temperature for 3.5 hours. Then, the reaction solution was poured into a beaker containing 35 tons of Celite, extracted with ethyl acetate in the same manner as in the previous example, dried over anhydrous sodium sulfate, and the solvent was distilled off.
(IR, 2B) -l-m by silica gel column chromatography (eluent: hexane-ethyl acetate = +:1)
0.263 r of an optically active form of -fluorophenyl-propane-12-diol was obtained as an oil. The yield was 31%.
赤外吸収(Neat)備−1
5400、5000,2950,16+5.1590.
+490゜1450、1250. +130.107
0. +040.1000゜核磁気共鳴吸収(cc 1
4)
δppm = 0.93(d、 3H)349(bro
ad El、2H)
3、85(dXquart、IH)
4.65(d、IH)
6.63〜7.23(m、4H)
質量分析スペクトル(m//zrθ11ntensit
y)170(0,3)、 152(2)、 126
(100)、 105(2す。Infrared absorption (Neat) equipment-1 5400, 5000, 2950, 16+5.1590.
+490°1450, 1250. +130.107
0. +040.1000° nuclear magnetic resonance absorption (cc 1
4) δppm = 0.93 (d, 3H) 349 (bro
ad El, 2H) 3,85 (dXquart, IH) 4.65 (d, IH) 6.63-7.23 (m, 4H) Mass spectrometry spectrum (m//zrθ11ntensit
y) 170(0,3), 152(2), 126
(100), 105 (2s.
97(81)、 77(16)、 45(20)、
28(N)比旋光度
(a 片’ −2a、s° (0= 1.97 (HC
I、)実施例6
乾燥酵母12.5f、グル:l−スIOS’、水道水5
0dをナスフラスコに秤シ取シ、N温で10分間撹拌シ
た。これGCO−フルオロペンズアルテヒト0.602
f (4,85mmol)のエタノール溶液1dを加
え、その−1ま室温で1時間撹拌した。ここで乾燥酵母
6.32とグルコース52を加え、更に3.5時間室温
で撹拌した。ついで、セライト35fを入れたビーカー
に反応液を注ぎ、以下実施例1と同様にして酢酸エチル
で抽出、無水硫激ナトリウムで乾燥し、溶媒を留去した
後、シリカゲルカラムクロマトグラフィー (溶離剤:
へΦサンー酢酸エチル=4:I)で(IR,2B) −
1−(0−フルオロフェニル)−70バy−1,2−ジ
オールの光学活性体を油状物として0.245?得た。97 (81), 77 (16), 45 (20),
28 (N) Specific optical rotation (a piece' -2a, s° (0 = 1.97 (HC
I,) Example 6 Dry yeast 12.5f, Glue: l-su IOS', tap water 5
0d was weighed into an eggplant flask and stirred at N temperature for 10 minutes. This GCO-Fluoropenzartecht 0.602
1 d of an ethanol solution of f (4.85 mmol) was added, and the mixture was stirred at room temperature for 1 hour. Here, 6.32 ml of dry yeast and 52 ml of glucose were added, and the mixture was further stirred at room temperature for 3.5 hours. Next, the reaction solution was poured into a beaker containing Celite 35f, extracted with ethyl acetate in the same manner as in Example 1, dried over anhydrous sodium sulfate, distilled off the solvent, and subjected to silica gel column chromatography (eluent:
to Φsan-ethyl acetate = 4:I) (IR, 2B) -
The optically active form of 1-(0-fluorophenyl)-70by-1,2-diol as an oil is 0.245? Obtained.
その収率は50%であった。The yield was 50%.
赤外吸収(Neat) an−’
3400、3000.2950.1620.1585.
1490゜1450、1220.1+80.1130.
990. 930゜核磁気共鳴吸収(CIC1*)
δppm = 0 、90 (d 、 3H)193(
m、2H+1H)
4.95(d、IH)
6.80〜7.63(m、 4H)
質量分析スペクトル(aI/z rel 1ntens
ity)170(0,5)、 152(2)、 12
5(100)、 105(52)。Infrared absorption (Neat) an-' 3400, 3000.2950.1620.1585.
1490°1450, 1220.1+80.1130.
990. 930° nuclear magnetic resonance absorption (CIC1*) δppm = 0, 90 (d, 3H) 193 (
m, 2H+1H) 4.95 (d, IH) 6.80-7.63 (m, 4H) Mass spectrometry spectrum (aI/z rel 1ntens
ity) 170(0,5), 152(2), 12
5 (100), 105 (52).
97(59)、 77(35)、 45(22)、 2
g(70)比旋光度
〔α) D −24,s° ((! = 2.440H
C’1.)実施例7
乾燥酵母12.5 f、 グルコース遣ay、水道水
50dをナスフラスコに秤り取シ、室温で10分間撹拌
した。これにp−メチルベンズアルデヒド0.606
f (5,05mmol)のエタノール溶液1dを加え
、そのまま室温で1時間撹拌した。ここで乾燥酵母6.
32とグルコース5fを加え、更に3.5時間室温で撹
拌した。ついで、セライト35?を入れたビーカーに反
応液を注ぎ、以下実施例1と同様にして酢酸エチルで抽
出、無水硫酸ナトリウムで乾燥し、溶媒を留去した後、
シリカゲルカラムクロマトグラフィー(溶離剤:ヘキサ
ンー酢酸エチル=4 : + )で(IR,2B) −
1−(p−メチルフェニル)−プロパン−1,2−ジオ
ールの光学活性体を油状物として0,255 f得た。97 (59), 77 (35), 45 (22), 2
g(70) Specific optical rotation [α) D −24,s° ((! = 2.440H
C'1. ) Example 7 12.5 f of dry yeast, 50 g of glucose, and 50 d of tap water were weighed into an eggplant flask and stirred at room temperature for 10 minutes. To this, p-methylbenzaldehyde 0.606
1 d of an ethanol solution of f (5.05 mmol) was added, and the mixture was stirred at room temperature for 1 hour. Here dry yeast 6.
32 and glucose 5f were added, and the mixture was further stirred at room temperature for 3.5 hours. Next, Celite 35? The reaction solution was poured into a beaker containing , extracted with ethyl acetate in the same manner as in Example 1, dried over anhydrous sodium sulfate, and the solvent was distilled off.
(IR, 2B) - by silica gel column chromatography (eluent: hexane-ethyl acetate = 4: +)
0.255 f of an optically active form of 1-(p-methylphenyl)-propane-1,2-diol was obtained as an oil.
その収率は28%であった。The yield was 28%.
赤外吸収(N 8a t ) cm−’3400 3
000 2950 1920 +720 1
7201710 +620 1520 145
0 1380 12001s5o、 jooo、
930. 860. 84o、 goo。Infrared absorption (N8at) cm-'3400 3
000 2950 1920 +720 1
7201710 +620 1520 145
0 1380 12001s5o, jooo,
930. 860. 84o, goo.
核磁気共鳴吸収(cc14)
δppm = 0.96(d、5H)
2.33(S、3H)
2.83(broad S、2H)
3.80(dXquart 、 IH)4.53(d、
IH)
6.87〜7.35(m、 4H)
質量分析スペクトル(m/z rel tntensl
ty)166(0,5)、 +49(Iす、 121(
100)、 93(48)。Nuclear magnetic resonance absorption (cc14) δppm = 0.96 (d, 5H) 2.33 (S, 3H) 2.83 (broad S, 2H) 3.80 (dXquart, IH) 4.53 (d,
IH) 6.87-7.35 (m, 4H) Mass spectrometry spectrum (m/z rel tntensl
ty) 166(0,5), +49(Isu, 121(
100), 93(48).
??(28)、 43(8)、 28(7)比旋光度
〔α〕!も’ −42,2° (0= 2.10
cHclm)実施例8
乾燥酵母12.5 f、グA コー スlof、水道水
50dをナスフラスコに秤り取り、室温で10分間撹拌
した。これにO−メチルベンズアルデヒド0、6+3
f (5,II mmol)のエタノール溶液1dを加
え、そのiま室温で1時間撹拌した。ここで乾燥酵母6
.32とグルコース5ノを加え、更に3.5時間室温で
撹拌した。ついで、セライト55Vを入れたビーカーに
反応液を注ぎ、以下実施例1と同様にして酢酸エチルで
抽出、無水硫酸ナトリウムで乾燥し1溶媒を留去した後
、シリカゲルカラムクロマトグラフィー(溶離剤:ヘキ
サン一酢酸エチル=4 : J )で(IR,2S)
−J−(0−メチルフェニル)−プロパン−1,2−ジ
オールの光学活性体を油状物として0.127 f得た
。その収率は7%であった。? ? (28), 43(8), 28(7) Specific rotation [α]! Also' -42,2° (0= 2.10
cHclm) Example 8 12.5 f of dry yeast, lof of GuA course, and 50 d of tap water were weighed into an eggplant flask and stirred at room temperature for 10 minutes. Add O-methylbenzaldehyde 0,6+3
1 d of an ethanol solution of f (5,II mmol) was added, and the mixture was stirred at room temperature for 1 hour. Here dry yeast 6
.. 32 and glucose were added, and the mixture was further stirred at room temperature for 3.5 hours. Next, the reaction solution was poured into a beaker containing Celite 55V, extracted with ethyl acetate in the same manner as in Example 1, dried over anhydrous sodium sulfate, distilled off one solvent, and then subjected to silica gel column chromatography (eluent: hexane). Ethyl monoacetate = 4: J) (IR, 2S)
0.127 f of an optically active form of -J-(0-methylphenyl)-propane-1,2-diol was obtained as an oil. The yield was 7%.
赤外吸収(Neat)国−1
5400、3000,2950,1700,1450,
1380゜目50. +070. 990. 950.
850. 750核磁気共鳴吸収(0014)
a ppm = + 、05(d、 3H)2jO(S
、3H)
2.82(broad 8,2H)
5.83(dXquart、IH)
4.83(d、IH)
6.83〜7.23(m、5H)
7.3G 〜7.50(m、IH)
質量分析スペクトル(ル/2 red intθnθ1
ty)182(5)、 164(3)、 +37(
100)、 +21(+9)。Infrared absorption (Neat) country-1 5400, 3000, 2950, 1700, 1450,
1380°50. +070. 990. 950.
850. 750 Nuclear Magnetic Resonance Absorption (0014) a ppm = +, 05(d, 3H)2jO(S
, 3H) 2.82 (broad 8, 2H) 5.83 (dXquart, IH) 4.83 (d, IH) 6.83 ~ 7.23 (m, 5H) 7.3G ~ 7.50 (m, IH) Mass spectrometry spectrum (Le/2 red intθnθ1
ty) 182(5), 164(3), +37(
100), +21 (+9).
+09(+9)、 94(目)、 77(10)、 2
B(39)比旋光度
〔α)”; −55,9° (0= 1,020
HO’ls)実施例9
乾燥酵母12.5 ?、グルコースlof、水道水50
dをナスフラスコに秤り取り、呈温で10分間撹拌した
。これにp−メトキシペンズアルテヒド0.608 F
(4,47mmol)のエタノール溶液1−を加え、
そのtま11&で1時間撹拌した。ここで乾燥酵母6.
3fとグルコース5fを加え1更に345時間室温で撹
拌した。ついで、セライト35Vを入れたビーカーに反
応液を注ぎ、以下実施列1と同様にして酢酸エチルで抽
出、無水硫酸ナトリウムで乾燥し、溶媒を留去した後、
シリカゲルカラムクロマトグラフィー(溶離剤:ヘキサ
ンー酢酸エチル=4:l)で(IR,2B) −1−(
p−メトキシフェニル)−プロパン−1,2−ジオール
の光学活性体を結晶として0.183を得た。その収率
は23%、融点94−95 ℃であった。+09 (+9), 94 (eyes), 77 (10), 2
B(39) Specific optical rotation [α)”; −55,9° (0= 1,020
HO'ls) Example 9 Dry yeast 12.5? , glucose lof, tap water 50
d was weighed into an eggplant flask and stirred at room temperature for 10 minutes. To this, p-methoxypenzaltehyde 0.608 F
(4.47 mmol) of ethanol solution 1- was added,
The mixture was stirred for 1 hour at 11°C. Here dry yeast 6.
3f and glucose 5f were added, and the mixture was further stirred at room temperature for 345 hours. Next, the reaction solution was poured into a beaker containing Celite 35V, and extracted with ethyl acetate in the same manner as in Example 1, dried over anhydrous sodium sulfate, and the solvent was distilled off.
(IR, 2B) -1-(
0.183 was obtained as a crystal of an optically active form of p-methoxyphenyl)-propane-1,2-diol. The yield was 23%, melting point 94-95°C.
赤外吸収(l橿θat)m−’
3450、3350.2970.1720.1610.
1580゜+510.1450.1410.1240.
1080.1020゜990、 860. 840.
800. 670. 580゜核磁気共鳴吸収(cc1
4)
δppm = 1.08((1,3)1)2.0(br
oad S、2H)
3.73〜4.10(m、3H)
4.90(d 、 IH)
6.87(d、2)i)
7.27(d、2H)
質量分析スペクトル(m/z rel 1nten++
1ty)1i(0,2)、 +49(2)、 122(
100)、 107(54)。Infrared absorption (l θat) m-' 3450, 3350.2970.1720.1610.
1580°+510.1450.1410.1240.
1080.1020°990, 860. 840.
800. 670. 580° nuclear magnetic resonance absorption (cc1
4) δppm = 1.08((1,3)1)2.0(br
oad S, 2H) 3.73-4.10 (m, 3H) 4.90 (d, IH) 6.87 (d, 2) i) 7.27 (d, 2H) Mass spectrometry spectrum (m/z rel 1nten++
1ty) 1i(0,2), +49(2), 122(
100), 107(54).
93(71)、 77(31)、 45(8)、 28
(38)比旋光度
〔α〕−3−35.9° (a : 1,02 cH
clg)実施例10
乾燥酵母12.5F、グルコースIOf、水道水50d
をナスフラスコに秤シ取シ、室温で10分間撹拌した。93(71), 77(31), 45(8), 28
(38) Specific rotation [α] -3-35.9° (a: 1,02 cH
clg) Example 10 Dry yeast 12.5F, glucose IOf, tap water 50d
The mixture was weighed out into an eggplant flask and stirred at room temperature for 10 minutes.
これにp−ニトロペンズアルテヒド0.601 ? (
3,98mmol)のエタノール溶液1−を加え、その
ままNaで1時間撹拌した。ここで乾燥酵母6.52と
グルコース52を加え、更に3.5時間室温で撹拌した
。ついで、セライト35tを入れたビーカーに反応液を
注ぎ、以下実施例1と同様にして酢酸エチルで抽出、無
水硫酸ナトリウムで乾燥し、溶媒を留去した後、シリカ
ゲルカラムクロマトグラフィー(溶離剤:ヘキサンー酢
酸エチル=+:+)で(IR,2B) −1−(p−ニ
トロフェニル)−プロパン−1,2−ジオールの光学活
性体を油状物として0.+099得た。その収率は14
%であった。Add p-nitropenzaltehyde 0.601 to this? (
3.98 mmol) of ethanol solution 1- was added thereto, and the mixture was stirred with Na for 1 hour. Here, 6.52 ml of dry yeast and 52 ml of glucose were added, and the mixture was further stirred at room temperature for 3.5 hours. Then, the reaction solution was poured into a beaker containing 35 tons of Celite, extracted with ethyl acetate in the same manner as in Example 1, dried over anhydrous sodium sulfate, distilled off the solvent, and subjected to silica gel column chromatography (eluent: hexane-hexane). The optically active form of (IR, 2B) -1-(p-nitrophenyl)-propane-1,2-diol was prepared as an oil using ethyl acetate=+:+). I got +099. The yield is 14
%Met.
赤外吸収(Neat) cm−’
3今00. 3000. 2900. +940
. 1605. 1520゜13’+0.1200
. 930. 11140. 810. 750゜核磁
気共鳴吸収(OC14)
δppm = 1.05(d、3H)
2.86(1,1road S、2H)4.10(dX
quart、IH)
7.50(d、2H)
8゜+6(d、2H)
質量分析スペクトル(m/z rel 1nto−sヱ
ty)+98(0,6)、 +81 (す、 +64(
0,8)、 +53(100)。Infrared absorption (Neat) cm-' 300. 3000. 2900. +940
.. 1605. 1520°13'+0.1200
.. 930. 11140. 810. 750° Nuclear Magnetic Resonance Absorption (OC14) δppm = 1.05 (d, 3H) 2.86 (1,1road S, 2H) 4.10 (dX
quart, IH) 7.50 (d, 2H) 8° + 6 (d, 2H) Mass spectrometry spectrum (m/z rel 1nto-sty) +98 (0,6), +81 (su, +64 (
0,8), +53 (100).
+56(83)、 +06(52)、 77(21)、
45(26)。+56 (83), +06 (52), 77 (21),
45 (26).
比旋光度
(α〕甘 −107,2° (C= 1.+54 c
Hcx、)特許出願人 セントラル硝子株式会社
手 続 補 正 誉(自発)
昭和61年1月叫日
特ffF庁長官宇買道部 殿
1、 ◆件の表示
昭和60年特ff頴第目3159号
2 発明の名称
光学活性ジオールの製造方法
3、 補正をする者
事件との関係 特許出願人
住所 山口県宇部市大字沖宇部5253%地氏名 (2
20)セントシル硝子株式会社代表者 伊 藤 三
艮
5、 補正により増加する発明の数 なし6、
補正の対象
明細書の特許請求の範囲の欄
および発明の詳細なIi5!明の欄
7、補正の内容
別紙の通り
補 正 書
」、 特a’を請求の範囲を仄のとおり補正する。Specific optical rotation (α) -107,2° (C= 1.+54 c
Hcx,) Patent Applicant Central Glass Co., Ltd. Procedural Amendment Homare (Voluntary) January 1985 Special FF Agency Director General Ubuyaki Michibe 1, ◆Indication of 1985 Special FF Issue No. 3159 2 Name of the invention Process for producing optically active diols 3 Relationship with the case of the person making the amendment Patent applicant address 5253% Oki-Ube, Ube-shi, Yamaguchi Prefecture Name (2)
20) San Ito, Representative of Centcil Glass Co., Ltd.
5. Number of inventions increased by amendment None 6.
Claims column of the specification subject to amendment and details of the invention Ii5! Column 7, Contents of the Amendment "Written Amendment" and Feature a' are amended to the extent that the scope of the claims is as shown in the appendix.
rテツ力ロミセス(saccharomyces )属
に属し、l−アリール7oパン−1,2−ジオール生成
能t−iする菌をベンズアルデヒドあるいは置換ベンズ
アルデヒドと糖類の存在下に撹拌培養し、該培養物から
(IR、28ノー1−アリールグロバンー1,2−ジオ
ールを採取することを特徴とする光学活性(IR,28
) −1−アリールプロパン−1,2−ジオールの製造
方法、」
λ 発明の詳細な説明の欄を次のとおり浦正する。A bacterium belonging to the genus Saccharomyces and capable of producing l-aryl7opan-1,2-diol was cultured with stirring in the presence of benzaldehyde or substituted benzaldehyde and sugars, and from the culture (IR , 28-1-arylgloban-1,2-diol (IR, 28
) -Method for producing 1-arylpropane-1,2-diol, λ The Detailed Description of the Invention column is edited as follows.
(リ 明細誓爾1頁第15竹、および第17行、四重2
貞寿2行の1−(1S,2R月をr(IR,2s月と補
正する。(Li Specifications page 1, line 15, and line 17, 4 layers 2
Correct the 1-(1S, 2R month of Teiju 2 line to r(IR, 2s month).
(2) 同第2頁第5行の「採取する一般式」を1採
取する」と補正する。(2) Amend the ``general formula for sampling'' on page 2, line 5 of the same document to read ``take 1 sample''.
(4) 同第2頁第5行の[(式中Xは〕くう位、」
を1(式中又は水素または)(う位、jと補正する。(4) On page 2, line 5, [(in the formula, X is] the ku place)
Correct it with 1 (in the formula or hydrogen or) (position, j).
(5)同第2貞第8〜9行の1p−メトキン等である)
」を「p−メトキシ等である)」と補正する。(5) 1p-Metkin, etc. in the 8th to 9th lines of the 2nd Sada)
" is corrected to "p-methoxy, etc.)".
(6)同県3貞第3行および第1O〜l1行の1°酸素
」を「#素Jと補正する。(6) 1°Oxygen in the 3rd row of the same prefecture and the 1st O to 11th lines is corrected to ``# element J.
(7)同第5貞第1行の「Xは0−クロロ、」をrxは
水素またはO−クロロ、」と補正する。(7) Correct "X is 0-chloro," in the first line of No. 5, to "rx is hydrogen or O-chloro."
(8) 同第10頁第7行の+−(m/2.jt−r
(m/Z、Jと補正する。(8) +-(m/2.jt-r on page 10, line 7)
(Correct as m/Z and J.
Claims (1)
し、1−アリールプロパン−1,2−ジオール生成能を
有する菌をベンズアルデヒドあるいは置換ベンズアルデ
ヒドと糖類の存在下に撹拌培養し、該培養物から(1S
,2R)−1−アリールプロパン−1,2−ジオールを
採取することを特徴とする光学活性(1S,2R)−1
−アリールプロパン−1,2−ジオールの製造方法。A bacterium belonging to the genus Saccharomyces and capable of producing 1-arylpropane-1,2-diol is cultured with stirring in the presence of benzaldehyde or substituted benzaldehyde and sugars, and from the culture (1S
,2R)-1-Arylpropane-1,2-diol is collected. Optical activity (1S,2R)-1
- Method for producing arylpropane-1,2-diol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11315985A JPS61271992A (en) | 1985-05-28 | 1985-05-28 | Production of optically active diol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11315985A JPS61271992A (en) | 1985-05-28 | 1985-05-28 | Production of optically active diol |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS61271992A true JPS61271992A (en) | 1986-12-02 |
Family
ID=14605046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11315985A Pending JPS61271992A (en) | 1985-05-28 | 1985-05-28 | Production of optically active diol |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61271992A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012002773A3 (en) * | 2010-07-02 | 2012-04-26 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
WO2013100571A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating als |
US8859817B2 (en) | 2011-01-13 | 2014-10-14 | Bio-Pharm Solutions Co., Ltd. | Process for preparation of phenyl carbamate derivatives |
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
US9566261B2 (en) * | 2013-03-12 | 2017-02-14 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same |
US9682059B2 (en) | 2013-03-12 | 2017-06-20 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome |
-
1985
- 1985-05-28 JP JP11315985A patent/JPS61271992A/en active Pending
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013535418A (en) * | 2010-07-02 | 2013-09-12 | バイオ−ファーム ソリューションズ カンパニー リミテッド | Phenyl carbamate compound and muscle relaxant containing the same |
CN103080079A (en) * | 2010-07-02 | 2013-05-01 | 比皮艾思药物研发有限公司 | Phenylcarbamate compound and muscle relaxant containing the same |
KR101532823B1 (en) * | 2010-07-02 | 2015-07-03 | (주)바이오팜솔루션즈 | Phenylcarbamate compound and muscle relaxant containing the same |
CN104628603A (en) * | 2010-07-02 | 2015-05-20 | 比皮艾思药物研发有限公司 | Phenylcarbamate compound and muscle relaxant containing the same |
US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
WO2012002773A3 (en) * | 2010-07-02 | 2012-04-26 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
US8859817B2 (en) | 2011-01-13 | 2014-10-14 | Bio-Pharm Solutions Co., Ltd. | Process for preparation of phenyl carbamate derivatives |
JP2015504055A (en) * | 2011-12-27 | 2015-02-05 | バイオ−ファーム ソリューションズ カンパニー リミテッド | Phenylcarbamate compounds used in the treatment or prevention of Luguelig disease |
US9034848B2 (en) | 2011-12-27 | 2015-05-19 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating stroke |
WO2013100569A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating multiple sclerosis |
CN104136413A (en) * | 2011-12-27 | 2014-11-05 | 比皮艾思药物研发有限公司 | Phenyl carbamate compounds for use in preventing or treating epilesy |
CN104136415A (en) * | 2011-12-27 | 2014-11-05 | 比皮艾思药物研发有限公司 | Phenyl carbamate compounds for use in preventing or treating stroke |
CN104136414A (en) * | 2011-12-27 | 2014-11-05 | 比皮艾思药物研发有限公司 | Phenyl carbamate compounds for use in preventing or treating multiple sclerosis |
CN104136416A (en) * | 2011-12-27 | 2014-11-05 | 比皮艾思药物研发有限公司 | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
CN104169253A (en) * | 2011-12-27 | 2014-11-26 | 比皮艾思药物研发有限公司 | Phenyl carbamate compounds for use in alleviating or treating pain |
JP2015503550A (en) * | 2011-12-27 | 2015-02-02 | バイオ−ファーム ソリューションズ カンパニー リミテッド | Phenyl carbamate compounds for use in the prevention or treatment of epilepsy |
WO2013100570A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating epilesy |
JP2015508398A (en) * | 2011-12-27 | 2015-03-19 | バイオ−ファーム ソリューションズ カンパニー リミテッド | Phenylcarbamate compounds for use in pain relief or treatment |
WO2013100566A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
US9029589B2 (en) | 2011-12-27 | 2015-05-12 | Bio-Pharm Solutions Co., Ltd. | Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same |
WO2013100568A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating stroke |
WO2013100567A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain |
WO2013100571A1 (en) * | 2011-12-27 | 2013-07-04 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating als |
CN104870421A (en) * | 2011-12-27 | 2015-08-26 | 比皮艾思药物研发有限公司 | Phenyl carbamate compounds for use in preventing or treating ALS |
US9162975B2 (en) | 2011-12-27 | 2015-10-20 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in alleviating or treating pain |
JP2017193577A (en) * | 2011-12-27 | 2017-10-26 | バイオ−ファーム ソリューションズ カンパニー リミテッド | Phenyl carbamate compounds for use in preventing or treating epilepsy |
US9624164B2 (en) | 2011-12-27 | 2017-04-18 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating epilepsy |
RU2632659C2 (en) * | 2011-12-27 | 2017-10-09 | Байо-Фарм Солюшнс Ко., Лтд. | Phenylcarbamate compounds for application in epilepsy prevention or treatment |
AU2012360362B2 (en) * | 2011-12-27 | 2017-08-31 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain |
US9682059B2 (en) | 2013-03-12 | 2017-06-20 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome |
US9566261B2 (en) * | 2013-03-12 | 2017-02-14 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same |
US9956197B2 (en) | 2013-03-12 | 2018-05-01 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndromes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS61271992A (en) | Production of optically active diol | |
Maezaki et al. | C 2-Symmetric Bis-sulfoxide: A Novel Chiral Auxiliary for Asymmetric Desymmetrization of Cyclic m eso-1, 2-Diols | |
JPS63284184A (en) | Optically active compound and production thereof | |
Franssen et al. | Resolution of a tetrahydrofuran ester by Candida rugosa lipase (CRL) and an examination of CRL's stereochemical preference in organic media | |
Chexal et al. | Gilmicolin and Mycorrhizinol, Two New Metabolites of Gilmaniella humicolaBARRON | |
CN86107090A (en) | The preparation method of Clausenamide | |
Izumi et al. | Enzymatic resolution of planar chiral ferrocene derivatives | |
Zhang et al. | The asymmetric total synthesis of (−)-Eurothiocin a and its enantiomer | |
Nakashima et al. | Chiral preparation of polyoxygenated cyclopentanoids | |
Takayasu et al. | Synthesis of the (9 R, 13 R)-isomer of LDS1, a flower-inducing oxylipin isolated from Lemna paucicostata | |
Fuentes et al. | Synthesis of optically active β′-hydroxy-β-enaminoketones via enzymatic resolution of carbinols derived from 3, 5-disubstituted isoxazoles | |
Tosi et al. | Biocatalytic asymmetric synthesis of (S)-and (R)-Timolol | |
JPS60251890A (en) | Preparation of gamma-halo-beta-hydroxybutyric ester | |
EP0280232B1 (en) | Monoacetylation of diols using a biocatalyst from corynebacterium oxydans | |
Stogryn | New synthesis of 3, 4-(difluoromethylenedioxy) benzaldehyde | |
JPS58126792A (en) | Preparation of optically active substance by microorganism | |
JP2808544B2 (en) | Optically active compound and method for producing the same | |
Miura et al. | A convenient synthesis of the (E)-monoacetates of 2-alkylidenepropane-1, 3-diols | |
Barnier et al. | Chemo-enzymatic preparations of (R)-and (S)-3-iodocyclohex-2-en-1-yl acetate | |
JPH01281098A (en) | Production of optically active carboxylic acid and optically active carboxylic acid ester | |
Kimura et al. | Chiral Preparation of C2-Symmetric 4-Cyclopentene-1, 3-diol | |
JPS61134339A (en) | Optically active alcohol produced by stereospecific reduction of alpha-diketone and production thereof | |
Chapleur et al. | A New General Method for the Synthesis of Optically Active Alkyl Azides | |
JPS6010719B2 (en) | Production method of β-hydroxy ester | |
JPH05194299A (en) | Optically active glycidol derivative and its production |